TrialTargeted oncology2023

A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).

Ryohei Kawabata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.